Abbott announced today that it entered a first-of-its-kind agreement to integrate data from its Libre systems into Epic EHR ...

AID system compatible with Senseonics Eversense® 365 one-year CGM system twiist with Eversense 365 launch expected in Q3 ...

Sequel Med Tech and Senseonics today announced a commercial development agreement to combine insulin delivery and glucose ...

Senseonics Holdings Inc. advanced stock charts by Barron's. View SENS historical stock data and compare to other stocks, and exchanges.

KOS AI Argus KOS AI, a Silicon Valley health technology firm, has developed a non-invasive glucose monitoring device t ...

Whichever category you fall into, you can take appropriate steps to control your glucose levels before ... they may also want to monitor your kidney function after the procedure to determine when you ...

Scientists have identified a simple, noninvasive method for assessing blood glucose regulation using continuous glucose monitoring (CGM) data. Their approach, which tracks glucose fluctuations, ...

Abbott's growth potential with GLP-1 tailwinds, robust FCF, and dividend growth. Read more on how ABT navigates tariffs while ...

Experts discuss the metrics used to evaluate continuous glucose monitoring (CGM)'s comprehensive return on investment, ...

Its primary product is the brand Eversense CGM (continuous glucose monitoring) including sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is ...

The following is a summary of “Evidence for improved glucose metrics and perinatal outcomes with continuous glucose ...

Glucotrack (Nasdaq:GCTK) may be bringing its continuous blood glucose monitor (CBGM) technology to automated insulin delivery ...